150 related articles for article (PubMed ID: 12419744)
21. Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: a phase II study.
Nolè F; Munzone E; Mandalà M; Catania C; Orlando L; Zampino MG; Minchella I; Colleoni M; Peruzzotti G; Marrocco E; Goldhirsch A
Ann Oncol; 2001 Jan; 12(1):95-100. PubMed ID: 11249057
[TBL] [Abstract][Full Text] [Related]
22. Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines.
Vassilomanolakis M; Koumakis G; Barbounis V; Demiri M; Pateras H; Efremidis AP
Ann Oncol; 2000 Sep; 11(9):1155-60. PubMed ID: 11061611
[TBL] [Abstract][Full Text] [Related]
23. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.
Hirose T; Mizutani Y; Ohmori T; Ishida H; Hosaka T; Ando K; Shirai T; Okuda K; Ohnishi T; Horichi N; Kubota H; Adachi M
Cancer Chemother Pharmacol; 2006 Sep; 58(3):361-7. PubMed ID: 16331494
[TBL] [Abstract][Full Text] [Related]
24. A clinical phase II study of a non-anthracycline sequential combination of cisplatin-vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer.
Shamseddine AI; Otrock ZK; Khalifeh MJ; Yassine HR; Charafeddine M; Abdel-Khalek Z; Chehal A; Bitar N; Jalloul R; Dheiny M; Dandashi A; Wehbeh M; El-Saghir NS
Oncology; 2006; 70(5):330-8. PubMed ID: 17164589
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
Br J Cancer; 1997; 76(11):1509-17. PubMed ID: 9400950
[TBL] [Abstract][Full Text] [Related]
26. [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma].
Bartsch V
Onkologie; 2006 Mar; 29 Suppl 1():1-28. PubMed ID: 16534241
[TBL] [Abstract][Full Text] [Related]
27. Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01).
Bennouna J; Havel L; Krzakowski M; Kollmeier J; Gervais R; Dansin E; Serke M; Favaretto A; Szczesna A; Cobo M; Ciuffreda L; Jassem J; Nicolini M; Ramlau R; Amoroso D; Melotti B; Almodovar T; Riggi M; Caux NR; Vaissière N; Tan EH
Clin Lung Cancer; 2014 Jul; 15(4):258-65. PubMed ID: 24954228
[TBL] [Abstract][Full Text] [Related]
28. UFT plus vinorelbine in advanced non-small cell lung cancer: a phase I and an elderly patient-directed phase II study.
Igishi T; Shigeoka Y; Yasuda K; Suyama H; Katayama S; Sugitani A; Matsumoto S; Yamamoto M; Ueda Y; Takeda K; Sumikawa T; Sako T; Kodani M; Hitsuda Y; Shimizu E
J Thorac Oncol; 2009 Mar; 4(3):376-82. PubMed ID: 19190514
[TBL] [Abstract][Full Text] [Related]
29. Vinorelbine Plus Gemcitabine or Cisplatin as First-line Treatment of HER2-negative Advanced Breast Cancer.
He K; Wang X; Guan X; Yu Q; Ma Q; Liu Z; Yu Z
Anticancer Res; 2017 Oct; 37(10):5647-5653. PubMed ID: 28982882
[TBL] [Abstract][Full Text] [Related]
30. Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial.
De Maio E; Pacilio C; Gravina A; Morabito A; Di Rella F; Labonia V; Landi G; Nuzzo F; Rossi E; Silvestro P; Botti G; Di Bonito M; Curcio MP; Formichelli F; La Vecchia F; Staiano M; Maurea N; D'Aiuto G; D'Aiuto M; Thomas R; Signoriello G; Perrone F; de Matteis A
BMC Cancer; 2007 Mar; 7():50. PubMed ID: 17374151
[TBL] [Abstract][Full Text] [Related]
31. Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer.
Gómez-Bernal A; Cruz JJ; Olaverri A; Arizcun A; Martín T; Rodríguez CA; Martín G; Fonseca E; Sánchez P
Anticancer Drugs; 2005 Jan; 16(1):77-82. PubMed ID: 15613908
[TBL] [Abstract][Full Text] [Related]
32. A phase II study of epirubicin, vinorelbine and cisplatin in advanced breast cancer.
Garrone O; Principe E; Occelli M; Mercuri M; Numico G; Granetto C; Di Costanzo G; Rattazzi PD; Merlano M
Anticancer Drugs; 2004 Jan; 15(1):23-7. PubMed ID: 15090739
[TBL] [Abstract][Full Text] [Related]
33. Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer.
Tan EH; Rolski J; Grodzki T; Schneider CP; Gatzemeier U; Zatloukal P; Aitini E; Carteni G; Riska H; Tsai YH; Abratt R
Ann Oncol; 2009 Jul; 20(7):1249-56. PubMed ID: 19276396
[TBL] [Abstract][Full Text] [Related]
34. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
[TBL] [Abstract][Full Text] [Related]
35. Daily times four vinorelbine plus cisplatin in advanced non-small-cell lung cancer: a phase II trial of a novel schedule.
Spiridonidis CH; Laufman LR; Jones JJ; Rhodes VA
Ann Oncol; 1999 Aug; 10(8):989-91. PubMed ID: 10509164
[TBL] [Abstract][Full Text] [Related]
36. A phase II study of intravenous navelbine and doxorubicin combination in previously untreated advanced breast carcinoma.
Pawlicki M; Rolski J; Zaluski J; Siedlecki P; Ramlau C; Tomzak P
Oncologist; 2002; 7(3):205-9. PubMed ID: 12065792
[TBL] [Abstract][Full Text] [Related]
37. Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study.
Serin D; Verrill M; Jones A; Delozier T; Coleman R; Kreuser ED; Mross K; Longerey B; Brandely M
Br J Cancer; 2005 Jun; 92(11):1989-96. PubMed ID: 15928659
[TBL] [Abstract][Full Text] [Related]
38. A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.
Vici P; Colucci G; Giotta F; Sergi D; Filippelli G; Perri P; Botti C; Vizza E; Carpino A; Pizzuti L; Latorre A; Giannarelli D; Lopez M; Di Lauro L
J Exp Clin Cancer Res; 2011 Apr; 30(1):39. PubMed ID: 21481280
[TBL] [Abstract][Full Text] [Related]
39. Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer.
Vassilomanolakis M; Koumakis G; Drufakou S; Aperis G; Demiri M; Barbounis V; Missitzis J; Efremidis AP
Cancer Chemother Pharmacol; 2003 Feb; 51(2):179-83. PubMed ID: 12647021
[TBL] [Abstract][Full Text] [Related]
40. Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study.
Oliva C; Bergnolo P; Inguì M; Bianco L; Pochettino P; Cutin SC; Boglione A; Dal Canton O; Garetto F; Comandone A
J Cancer Res Clin Oncol; 2010 Mar; 136(3):411-7. PubMed ID: 19727815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
